Evidence map›Paper›PMID 30040527›Full record

ArticleGut microbes2019

Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids.

Xu Han, Allen Lee, Sha Huang, Jun Gao, Jason R Spence, Chung Owyang

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Effects of specialized proresolving mediators on gut epithelial barrier in early life.The Journal of pharmacology and experimental therapeutics · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  17. Article
  18. Ion transport and epithelial barrier dysfunction in experimental models of ulcerative colitis.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Review
  19. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xu Hana University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .ORCID 0000-0003-2407-7179
Allen Leea University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .ORCID 0000-0002-4861-7646
Sha Huanga University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .
Jun Gaoa University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .
Jason R Spencea University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .
Chung Owyanga University of Michigan , Department of Internal Medicine, Division of Gastroenterology and Hepatology , Ann Arbor , MI , USA .
University of Michigan · US

Funding

University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Stem Cell Differentiation CoreU19AI116482 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TAKAYAMA, SHUICHI · 2015 to 2019
$6.4M
Niche support of human intestinal stem cellsU01DK103141 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPENCE, JASON · 2014 to 2023
$3.9M
VAGAL ACTION OF CCK ON PANCREATIC SECRETIONR01DK048419 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1994 to 2015
$3.8M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
Modulation of Visceral Hypersensitivity in IBS by Lipid MediatorsR01DK110436 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRABAUSKAS, GINTAUTAS, OWYANG, CHUNG · 2016 to 2019
$1.7M
NIAID NIH HHS U19 AI116482NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R01 DK048419NIDDK NIH HHS R01 DK110436NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK103141NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

Disruption of intestinal barrier homeostasis is an important pathogenic factor in conditions such as irritable bowel syndrome (IBS). Lactobacillus rhamnosus GG (LGG) improves IBS symptoms through unclear mechanisms. Previous studies utilizing colorectal adenocarcinoma cell lines showed that LGG metabolites prevented interferon gamma (IFN-gamma) induced barrier damage but the model employed limited these findings. We aimed to interrogate the protective effects of LGG on epithelial barrier function using human intestinal epithelial cultures (enteroids and colonoids) as a more physiologic model. To investigate how LGG affects epithelial barrier function, we measured FITC-Dextran (FD4) flux across the epithelium as well as tight junction zonula occludens 1 (ZO-1) and occludin (OCLN) expression. Colonoids were incubated with fecal supernatants from IBS patients (IBS-FSN) and healthy controls in the presence or absence of LGG to examine changes in gut permeability. Enteroids incubated with IFN-gamma demonstrated a downregulation of OCLN and ZO-1 expression by 67% and 50%, respectively (p<0.05). This was accompanied by increased paracellular permeability as shown by leakage of FD4. Pretreatment of enteroids with LGG prevented these changes and normalized OCLN and ZO-1 to control levels. These actions were independent of its action against apoptosis. However, these protective effects were not seen with LGG cell wall extracts, LGG DNA, or denatured (boiled) LGG. Intriguingly, IBS-FSN injected into colonoids increased paracellular permeability, which was prevented by LGG. LGG, likely due to secreted proteins, protects against epithelial barrier dysfunction. Bacterial-derived factors to modulate gut barrier function may be a treatment option in disorders such as IBS.

Indexed as

Cell Culture TechniquesColonCulture Media, ConditionedFecesGene Expression RegulationHumansInterferon-gammaIntestinal MucosaIntestinesIrritable Bowel SyndromeLacticaseibacillus rhamnosusPermeabilityTight Junction ProteinsTight JunctionsCulture Media, ConditionedInterferon-gammaTight Junction Proteinsepithelial barrier functionhuman colonoidshuman intestinal enteroidsIFN-gammairritable bowel syndromeLactobacillus rhamnosus GG metabolitestight junction

Identifiers

PMID30040527
PMCPMC6363076
OpenAlexW2884154656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.